0.10
+0.001(+1.00%)
Currency In USD
| Previous Close | 0.1 |
| Open | 0.1 |
| Day High | 0.1 |
| Day Low | 0.09 |
| 52-Week High | 1.5 |
| 52-Week Low | 0.09 |
| Volume | 3.29M |
| Average Volume | 13.37M |
| Market Cap | 14.49M |
| PE | -1.01 |
| EPS | -0.1 |
| Moving Average 50 Days | 0.33 |
| Moving Average 200 Days | 0.49 |
| Change | 0 |
If you invested $1000 in Applied Therapeutics, Inc. (APLT) since IPO date, it would be worth $10.71 as of January 13, 2026 at a share price of $0.101. Whereas If you bought $1000 worth of Applied Therapeutics, Inc. (APLT) shares 5 years ago, it would be worth $4.58 as of January 13, 2026 at a share price of $0.101.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cycle Pharmaceuticals to Acquire Applied Therapeutics
GlobeNewswire Inc.
Dec 11, 2025 10:25 PM GMT
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseasesNEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Na
Applied Therapeutics Announces Corporate Updates
GlobeNewswire Inc.
Nov 20, 2025 12:00 PM GMT
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therap
Applied Therapeutics Provides Update Following Meeting with FDA
GlobeNewswire Inc.
Sep 29, 2025 11:00 AM GMT
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company com